CN Patent

CN120530113A — 经取代的四氢吡咯并-吡啶酮化合物及其在治疗医学病状中的用途

Assigned to Karuna Therapeutics Inc · Expires 2025-08-22 · 1y expired

What this patent protects

本发明提供了经取代的四氢吡咯并‑吡啶酮化合物、药物组合物及其在治疗毒蕈碱乙酰胆碱受体介导的病症中的用途。

USPTO Abstract

本发明提供了经取代的四氢吡咯并‑吡啶酮化合物、药物组合物及其在治疗毒蕈碱乙酰胆碱受体介导的病症中的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN120530113A
Jurisdiction: CN
Classification: —
Expires: 2025-08-22
Drug substance claim: No
Drug product claim: No
Assignee: Karuna Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.